CG肿瘤制药 CGON
$75.99 +$11.19 (+17.27%)
休市 · Nov 7, 10:50 pm ET · 最新盘后价 $76.05 +0.08%
开盘$66.49
昨收$64.80
当日区间$66.17 – $80.03
成交量3.66M
市值$6.74B
市盈率（TTM）–
股息率–
CGON 相关新闻
匹配 CG Oncology 或代码 CGON 的头条新闻，按最新排序。
- Analysts' Top Healthcare Picks: CG Oncology, Inc. (CGON), Opus Genetics (IRD)
- Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating
- A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $85 to $108
- Bank of America Securities Reaffirms Their Buy Rating on CG Oncology, Inc. (CGON)
- Analysts' Top Healthcare Picks: Annexon Biosciences (ANNX), CG Oncology, Inc. (CGON)
- Analysts' Top Healthcare Picks: InflaRx (IFRX), CG Oncology, Inc. (CGON)
- A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $79 to $100
- CG Oncology, Inc. (CGON) Gets a Buy From Piper Sandler
- UBS Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $90
- UBS Keeps Their Buy Rating on CG Oncology, Inc. (CGON)
- Morgan Stanley Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $93
- Analysts' Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)
- Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $85
- H.C. Wainwright Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $100
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Phibro Animal Health (PAHC), Universal Health (UHS) and CG Oncology, Inc. (CGON)
暂无评论——快来第一个聊聊 CGON。
登录后参与讨论。